179 related articles for article (PubMed ID: 15041081)
1. Differences in the hepatic P450-dependent metabolism of estrogen and tamoxifen in response to treatment of rats with 3,3'-diindolylmethane and its parent compound indole-3-carbinol.
Parkin DR; Malejka-Giganti D
Cancer Detect Prev; 2004; 28(1):72-9. PubMed ID: 15041081
[TBL] [Abstract][Full Text] [Related]
2. Modulations of P450 mRNA in liver and mammary gland and P450 activities and metabolism of estrogen in liver by treatment of rats with indole-3-carbinol.
Horn TL; Reichert MA; Bliss RL; Malejka-Giganti D
Biochem Pharmacol; 2002 Aug; 64(3):393-404. PubMed ID: 12147290
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of a dietary phytochemical 3,3'-diindolylmethane on the phenobarbital-induced hepatic CYP mRNA expression and CYP-catalyzed reactions in female rats.
Parkin DR; Lu Y; Bliss RL; Malejka-Giganti D
Food Chem Toxicol; 2008 Jul; 46(7):2451-8. PubMed ID: 18486294
[TBL] [Abstract][Full Text] [Related]
4. Oxidations of 17beta-estradiol and estrone and their interconversions catalyzed by liver, mammary gland and mammary tumor after acute and chronic treatment of rats with indole-3-carbinol or beta-naphthoflavone.
Ritter CL; Prigge WF; Reichert MA; Malejka-Giganti D
Can J Physiol Pharmacol; 2001 Jun; 79(6):519-32. PubMed ID: 11430590
[TBL] [Abstract][Full Text] [Related]
5. Concurrent flavin-containing monooxygenase down-regulation and cytochrome P-450 induction by dietary indoles in rat: implications for drug-drug interaction.
Katchamart S; Stresser DM; Dehal SS; Kupfer D; Williams DE
Drug Metab Dispos; 2000 Aug; 28(8):930-6. PubMed ID: 10901703
[TBL] [Abstract][Full Text] [Related]
6. Suppression of mammary gland carcinogenesis by post-initiation treatment of rats with tamoxifen or indole-3-carbinol or their combination.
Malejka-Giganti D; Parkin DR; Bennett KK; Lu Y; Decker RW; Niehans GA; Bliss RL
Eur J Cancer Prev; 2007 Apr; 16(2):130-41. PubMed ID: 17297389
[TBL] [Abstract][Full Text] [Related]
7. Dietary indole-3-carbinol promotes endometrial adenocarcinoma development in rats initiated with N-ethyl-N'-nitro-N-nitrosoguanidine, with induction of cytochrome P450s in the liver and consequent modulation of estrogen metabolism.
Yoshida M; Katashima S; Ando J; Tanaka T; Uematsu F; Nakae D; Maekawa A
Carcinogenesis; 2004 Nov; 25(11):2257-64. PubMed ID: 15240508
[TBL] [Abstract][Full Text] [Related]
8. Endocrine disruption by indole-3-carbinol and tamoxifen: blockage of ovulation.
Gao X; Petroff BK; Oluola O; Georg G; Terranova PF; Rozman KK
Toxicol Appl Pharmacol; 2002 Sep; 183(3):179-88. PubMed ID: 12383709
[TBL] [Abstract][Full Text] [Related]
9. Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation.
Jellinck PH; Forkert PG; Riddick DS; Okey AB; Michnovicz JJ; Bradlow HL
Biochem Pharmacol; 1993 Mar; 45(5):1129-36. PubMed ID: 8384853
[TBL] [Abstract][Full Text] [Related]
10. Effect of dietary indole-3-carbinol on intestinal and hepatic monooxygenase, glutathione S-transferase and epoxide hydrolase activities in the rat.
Bradfield CA; Bjeldanes LF
Food Chem Toxicol; 1984 Dec; 22(12):977-82. PubMed ID: 6334634
[TBL] [Abstract][Full Text] [Related]
11. Effects of 5,6-benzoflavone, indole-3-carbinol (I3C) and diindolylmethane (DIM) on chemically-induced mammary carcinogenesis: is DIM a substitute for I3C?
Lubet RA; Heckman BM; De Flora SL; Steele VE; Crowell JA; Juliana MM; Grubbs CJ
Oncol Rep; 2011 Sep; 26(3):731-6. PubMed ID: 21617870
[TBL] [Abstract][Full Text] [Related]
12. Organ-selective induction of cytochrome P-450-dependent activities by indole-3-carbinol-derived products: influence on covalent binding of benzo[a]pyrene to hepatic and pulmonary DNA in the rat.
Park JY; Bjeldanes LF
Chem Biol Interact; 1992 Aug; 83(3):235-47. PubMed ID: 1516151
[TBL] [Abstract][Full Text] [Related]
13. Induction of hepatic CYP1A by indole-3-carbinol in protection against aflatoxin B1 hepatocarcinogenesis in rainbow trout.
Takahashi N; Stresser DM; Williams DE; Bailey GS
Food Chem Toxicol; 1995 Oct; 33(10):841-50. PubMed ID: 7590528
[TBL] [Abstract][Full Text] [Related]
14. The anti-carcinogenic plant compound indole-3-carbinol differentially modulates P450-mediated steroid hydroxylase activities in mice.
Baldwin WS; LeBlanc GA
Chem Biol Interact; 1992 Aug; 83(2):155-69. PubMed ID: 1505058
[TBL] [Abstract][Full Text] [Related]
15. Toxicogenomic profiling of the hepatic tumor promoters indole-3-carbinol, 17beta-estradiol and beta-naphthoflavone in rainbow trout.
Tilton SC; Givan SA; Pereira CB; Bailey GS; Williams DE
Toxicol Sci; 2006 Mar; 90(1):61-72. PubMed ID: 16192472
[TBL] [Abstract][Full Text] [Related]
16. Indole-3-carbinol and beta-naphthoflavone induction of aflatoxin B1 metabolism and cytochromes P-450 associated with bioactivation and detoxication of aflatoxin B1 in the rat.
Stresser DM; Bailey GS; Williams DE
Drug Metab Dispos; 1994; 22(3):383-91. PubMed ID: 8070314
[TBL] [Abstract][Full Text] [Related]
17. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and diindolylmethanes differentially induce cytochrome P450 1A1, 1B1, and 19 in H295R human adrenocortical carcinoma cells.
Sanderson JT; Slobbe L; Lansbergen GW; Safe S; van den Berg M
Toxicol Sci; 2001 May; 61(1):40-8. PubMed ID: 11294972
[TBL] [Abstract][Full Text] [Related]
18. Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane.
Chen I; McDougal A; Wang F; Safe S
Carcinogenesis; 1998 Sep; 19(9):1631-9. PubMed ID: 9771935
[TBL] [Abstract][Full Text] [Related]
19. The aromatase inactivator 4-hydroxyandrostenedione (4-OH-A) inhibits tamoxifen metabolism by rat hepatic cytochrome P-450 3A: potential for drug-drug interaction of tamoxifen and 4-OH-A in combined anti-breast cancer therapy.
Dehal SS; Brodie AM; Kupfer D
Drug Metab Dispos; 1999 Mar; 27(3):389-94. PubMed ID: 10064571
[TBL] [Abstract][Full Text] [Related]
20. N-methoxyindole-3-carbinol is a more efficient inducer of cytochrome P-450 1A1 in cultured cells than indol-3-carbinol.
Stephensen PU; Bonnesen C; Schaldach C; Andersen O; Bjeldanes LF; Vang O
Nutr Cancer; 2000; 36(1):112-21. PubMed ID: 10798223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
